Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.54 |
| ▸ | RAB9A | P51151 | 9/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 7/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | STAT1 | P42224 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19388861 | 0.84 | RAB9A (0.43) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL10715419 | 0.81 | MAPK1 (0.42) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL18692224 | 0.81 | MEN1 (0.54) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL20386597 | 0.81 | NPC1 (0.53) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL18593711 | 0.81 | RAB9A (0.62) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL19732026 | 0.80 | PTGS1 (0.57) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL7837159 | 0.79 | CYP1A2 (0.66) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL14554235 | 0.77 | LMNA (0.69) | SMN1; SMN2RAB9AALDH1A1KMT2AMEN1 | |
| SCHEMBL20386582 | 0.77 | SMN1; SMN2 (0.41) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A | |
| SCHEMBL19750006 | 0.77 | NPY5R (0.44) | CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12180187-B2 | 1-phenyl-5-azinylpyrazolyl-3-oxyalkyl acids and their use for controlling unwanted plant growth | BAYER AKTIENGESELLSCHAFT (DE) | 2024-12-31 | — | — | US | disclosed |
| CN-114071999-B | 1-Phenyl-5-azinylpyrazolyl-3-oxyalkyl acids and their use for controlling unwanted plant growth | 拜耳公司 | 2024-08-27 | — | — | CN | disclosed |
| US-20230066946-A1 | 1,5-DIPHENYLPYRAZOLYL-3-OXYALKYL ACIDS AND 1-PHENYL-5-THIENYLPYRAZOLYL-3-OXYALKYL ACIDS AND THE USE THEREOF FOR CONTROL OF UNWANTED PLANT GROWTH | BAYER AKTIENGESELLSCHAFT (DE) | 2023-03-02 | — | — | US | disclosed |
| EP-4075979-A1 | 1,5-DIPHENYLPYRAZOLYL-3-OXYALKYL ACIDS AND 1-PHENYL-5-THIENYLPYRAZOLYL-3-OXYALKYL ACIDS AND THE USE THEREOF FOR CONTROL OF UNDESIRED PLANT GROWTH | Bayer Aktiengesellschaft (DE) | 2022-10-26 | — | — | EP | disclosed |
| CN-115135152-A | 1, 5-diphenylpyrazolyl-3-oxyalkyl acids and 1-phenyl-5-thienylpyrazolyl-3-oxyalkyl acids and their use for controlling undesired vegetation | 拜耳公司 | 2022-09-30 | — | — | CN | disclosed |
| US-20220235036-A1 | 1-PHENYL-5-AZINYLPYRAZOLYL-3-OXYALKYL ACIDS AND THEIR USE FOR CONTROLLING UNWANTED PLANT GROWTH | BAYER AKTIENGESELLSCHAFT (DE) | 2022-07-28 | — | — | US | disclosed |
| EP-3975720-A1 | 1-PHENYL-5-AZINYL PYRAZOLYL-3-OXYALKYL ACIDS AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH | Bayer Aktiengesellschaft (DE) | 2022-04-06 | — | — | EP | disclosed |
| CN-114071999-A | 1-phenyl-5-azinylpyrazolyl-3-oxyalkyl acids and their use for controlling undesired vegetation | 拜耳公司 | 2022-02-18 | — | — | CN | disclosed |
| WO-2021122728-A1 | 1,5-DIPHENYLPYRAZOLYL-3-OXYALKYL ACIDS AND 1-PHENYL-5-THIENYLPYRAZOLYL-3-OXYALKYL ACIDS AND THE USE THEREOF FOR CONTROL OF UNDESIRED PLANT GROWTH | BAYER AKTIENGESELLSCHAFT (DE) | 2021-06-24 | — | — | WO | disclosed |
| WO-2020245044-A1 | 1-PHENYL-5-AZINYL PYRAZOLYL-3-OXYALKYL ACIDS AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH | BAYER AKTIENGESELLSCHAFT (DE) | 2020-12-10 | — | — | WO | disclosed |
| US-10358445-B2 | Respiratory formulations and compounds for use therein | Respivert, Ltd. (GB) | 2019-07-23 | — | — | US | disclosed |
| US-20180201611-A1 | Respiratory formulations and compounds for use therein | RESPIVERT LTD. (GB) | 2018-07-19 | — | — | US | disclosed |
| WO-2012149157-A2 | HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK | BIOENERGENIX (US) | 2012-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10358445-B2 | Respiratory formulations and compounds for use therein | TSLP, CCL11, RORB | CYP1A2 117/4885CYP2C19 304/4885MAPK1 2007/4885 |
| US-12180187-B2 | 1-phenyl-5-azinylpyrazolyl-3-oxyalkyl acids and their use for controlling unwanted plant growth | AGPS, CYP51A1, PGLS | CYP1A2 208/4885CYP2C19 1555/4885MAPK1 777/4885 |
| US-20230066946-A1 | 1,5-DIPHENYLPYRAZOLYL-3-OXYALKYL ACIDS AND 1-PHENYL-5-THIENYLPYRAZOLYL-3-OXYALKYL ACIDS AND THE USE THEREOF FOR CONTROL OF UNWANTED PLANT GROWTH | NOTUM, AGPS, DDT | CYP1A2 291/4885CYP2C19 638/4885MAPK1 1888/4885 |
| US-20220235036-A1 | 1-PHENYL-5-AZINYLPYRAZOLYL-3-OXYALKYL ACIDS AND THEIR USE FOR CONTROLLING UNWANTED PLANT GROWTH | AGPS, CYP51A1, PGLS | CYP1A2 208/4885CYP2C19 1555/4885MAPK1 777/4885 |
| US-20180201611-A1 | Respiratory formulations and compounds for use therein | TSLP, CCL11, RORB | CYP1A2 117/4885CYP2C19 304/4885MAPK1 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.